MIG
EFTRW

Mariner Investment Group’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Mariner Investment Group’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,935
Closed -$37K – 199
2021
Q3 		$37K Buy
+22,935
New +$27.8K 0.1% 100

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Mariner Investment Group's EFTRW Position: Q4 2021 in Review

Mariner Investment Group sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q4 2021, closing a stake of 22,935 shares — an estimated $37K sold.

Mariner Investment Group first reported a position in EFTRW in Q3 2021 and held it in 1 quarter. The position peaked at $37K in Q3 2021. 17 funds tracked by Wall St. Rank hold EFTRW as of Q4 2021.

  • Mariner Investment Group reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • Mariner Investment Group sold 22,935 eFFECTOR Therapeutics, Inc. Warrant shares in Q4 2021, an estimated $37K.
  • Mariner Investment Group first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q3 2021 and held it in 1 quarter.
  • Mariner Investment Group's eFFECTOR Therapeutics, Inc. Warrant position peaked at $37K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q4 2021.

Based on Mariner Investment Group's 13F filing for Q4 2021, filed 9 Feb 2022.